Lataa...
Performance of the QPLEX™ Alz plus assay, a novel multiplex kit for screening cerebral amyloid deposition
BACKGROUND: Alzheimer’s disease (AD) is an irreversible neurodegenerative disease characterized by the hallmark finding of cerebral amyloid deposition. Many researchers have tried to predict the existence of cerebral amyloid deposition by using easily accessible blood plasma samples, but the effecti...
Tallennettuna:
| Julkaisussa: | Alzheimers Res Ther |
|---|---|
| Päätekijät: | , , , , , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
BioMed Central
2021
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7786945/ https://ncbi.nlm.nih.gov/pubmed/33407839 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13195-020-00751-x |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|